Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads: A pilot study focused on sustained tumor necrosis

CardioVascular and Interventional Radiology

Volumn 33, Issue 5, 2010, Pages 1022-1027

  Moschouris, Hippocrates ^a   Malagari, Katerina ^b   Papadaki, Marina Georgiou ^a   Kornezos, Ioannis ^a   Matsaidonis, Dimitrios ^a  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Contrast enhanced ultrasonography; Drug eluting beads; Hepatocellular carcinoma; Transarterial chemoembolisation

Indexed keywords

DOXORUBICIN; SONOVUE;

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG ELUTING BEAD; DRUG RESPONSE; ECHOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; PILOT STUDY; PRIORITY JOURNAL; TUMOR NECROSIS; TUMOR VASCULARIZATION; TUMOR VOLUME; VASCULAR PATENCY;

AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; NECROSIS; NEOPLASM STAGING; PHOSPHOLIPIDS; PILOT PROJECTS; SAMPLING STUDIES; SULFUR HEXAFLUORIDE; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77957748798     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-010-9800-7     Document Type: Article

References (21)

1. AL Lewis MV Gonzalez SW Leppard JE Brown PW Stratford GJ Phillips, et al. 2007 Doxorubicin eluting beads-1: effects of drug loading on bead characteristics and drug distribution J Mater Sci Mater Med 18 1691 1699 1:CAS:528:DC%2BD2sXos1Cgu7o%3D 10.1007/s10856-007-3068-8 17483878 (Pubitemid 47224923)
2. M Varela MI Real M Burrel A Forner M Sala M Brunet, et al. 2007 Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics J Hepatol 46 474 481 1:CAS:528: DC%2BD2sXhtlCmtb0%3D 10.1016/j.jhep.2006.10.020 17239480 (Pubitemid 46201723)
3. K Malagari E Alexopoulou K Chatzimichail B Hall J Koskinas S Ryan, et al. 2008 Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead Abdom Imaging 33 512 519 10.1007/s00261-007-9334-x 17938995
4. K Malagari K Chatzimichael E Alexopoulou A Kelekis B Hall S Dourakis, et al. 2008 Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients Cardiovasc Intervent Radiol 31 269 280 10.1007/s00270-007-9226-z 17999110
5. C Aliberti G Benea M Tilli G Fiorentini 2008 Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results Cardiovasc Intervent Radiol 31 5 883 888 10.1007/s00270-008-9336-2 18478290
6. C Aliberti M Tilli G Benea G Fiorentini 2006 Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results Anticancer Res 26 5B 3793 3795 1:STN:280:DC%2BD28nlvF2mtw%3D%3D 17094403
7. K Hong A Khwaja E Liapi MS Torbenson CS Georgiades JF Geschwind 2006 New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer Clin Cancer Res 12 2563 2567 1:CAS:528:DC%2BD28XjvValu7k%3D 10.1158/1078-0432.CCR-05-2225 16638866
8. AL Lewis RR Taylor B Hall MV Gonzalez SL Willis PW Stratford 2006 Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization J Vasc Interv Radiol 17 1335 1343 10.1097/01.RVI.0000228416.21560.7F 16923981 (Pubitemid 44259017)
9. J Bruix M Sherman JM Llovet M Beaugrand R Lencioni AK Burroughs, et al. 2001 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421 430 1:STN:280:DC%2BD3MrksFCmtg%3D%3D 10.1016/S0168-8278(01) 00130-1 11592607 (Pubitemid 32844200)
10. P Therasse SG Arbuck EA Eisenhauer J Wanders RS Kaplan L Rubinstein, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10.1093/jnci/92.3.205 10655437
11. GS Smith BA Birnbaum JE Jacobs 1998 Hepatic infarction secondary to arterial insufficiency in native livers: CT findings in 10 patients Radiology 208 223 229 1:STN:280:DyaK1czhtVOrtw%3D%3D 9646817
12. K Numata K Tanaka T Kiba S Saito T Isozaki K Hara, et al. 2001 Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma AJR Am J Roentgenol 176 1199 1205 1:STN:280:DC%2BD3MzotlSmug%3D%3D 11312181
13. H Ding M Kudo H Onda Y Suetomi Y Minami H Chung, et al. 2001 Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT Radiology 221 721 730 1:STN:280:DC%2BD3MnntlOqtw%3D%3D 10.1148/radiol.2213010358 11719668
14. Y Minami M Kudo T Kawasaki M Kitano H Chung K Maekawa, et al. 2003 Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography AJR Am J Roentgenol 180 703 708 12591679
15. M Morimoto K Shirato K Sugimori A Kokawa N Tomita T Saito, et al. 2003 Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma AJR Am J Roentgenol 181 65 69 12818831
16. M Pompili L Riccardi M Covino B Barbaro C Di Stasi R Orefice, et al. 2005 Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma Liver Int 25 954 961 10.1111/j.1478-3231.2005.01135.x 16162152 (Pubitemid 41404015)
17. HJ Kim TK Kim PN Kim AY Kim EY Ko KW Kim, et al. 2006 Assessment of the therapeutic response of hepatocellular carcinoma treated with transcatheter arterial chemoembolization: comparison of contrast-enhanced sonography and 3-phase computed tomography J Ultrasound Med 25 477 486 16567437
18. Y Kono O Lucidarme SH Choi SC Rose TI Hassanein E Alpert, et al. 2007 Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma J Vasc Interv Radiol 18 57 65 10.1016/j.jvir.2006.10.016 17296705 (Pubitemid 46628941)
19. Y Xia M Kudo Y Minami K Hatanaka K Ueshima H Chung, et al. 2008 Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography Oncology 75 99 105 10.1159/000173430 19092278
20. N Lassau M Lamuraglia L Chami J Leclère S Bonvalot P Terrier, et al. 2006 Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography AJR Am J Roentgenol 187 1267 1273 10.2214/AJR.05.1192 17056915 (Pubitemid 44630831)
21. Kloeckner R, Otto G, Biesterfeld S, Oberholzer K, Dueber C, Pitton MB (2009) MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol [Epub ahead of print]